Stock ANIK ANIKA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Real-time Estimate Cboe BZX
Other stock markets
 12:35:51 2024-04-24 pm EDT 		5-day change 1st Jan Change
26.11 USD +1.24% Intraday chart for Anika Therapeutics, Inc. +1.19% +14.72%
Mar. 14 Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating MT
Mar. 13 Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
GL
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating
MT
Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Anika: Q4 Earnings Snapshot
AQ
Anika Therapeutics Swings to Q4 Earnings As Revenue Rises; to Cut 9% Workforce
MT
Anika Therapeutics Guides For FY 2024 Revenue of $168-$173 Million, vs CIQ Analyst Consensus of $179 Million
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q4 EPS $0.05, vs. Street Est of $-0.23
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Posts Q4 Revenue $43M, vs. Street Est of $41.4M
MT
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
AQ
Anika Therapeutics, Inc. Provides Earnings Guidance for the Fiscal Year 2024
CI
Anika Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Anika Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Activist investor Caligan discloses 9.7% stake in Anika, nominates two director candidates
RE
Caligan Partners LP Issues Notice of Nominations to Anika Therapeutics, Inc
CI
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
GL
Anika Therapeutics, Inc. Announces Board Changes
CI
Anika Highlights Its Recently Launched IntegrityTM Implant System and RevoMotionTM Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products during the 2024 AAOS Annual Meeting
AQ
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIK Stock
  4. News Anika Therapeutics, Inc.